In approximately two-thirds of AML cases, recurrent mutations in genes encoding hematopoietic receptor tyrosine kinases or related proteins initiate or amplify signaling initiated by cytokine ligation to promote activation of intracellular signaling cascades [12]. Here, NTRK1 is linked to acute myeloid leukemia.